The Center for Disease Control is awarding the University of Arizona $22 million that will enable the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance, or AZ HEROES, to conduct a third year of COVID-19 research.
Biotech meets in person / Tech Nation Radio
Richard Austin, founder and CEO of Tucson-based Reglagene, talks with NPR’s Moira Gunn about choosing the company’s first-in-human drug for the brain cancer, glioblastoma.
Study finds common herbicide could be causing Alzheimer’s / Environment Journal
Researchers from TGen studied how exposure to a common herbicide, glyphosate, would affect mice brains, discovering that it could cross the blood-brain barrier.
Dr. Phillip Koo, chief of diagnostic imaging at Banner MD Anderson Cancer Center, talks about a new treatment for prostate cancer patients recently approved by the Food and Drug Administration.
Updated federal guidance for the first time in weeks has lifted an indoor face mask recommendation in Arizona’s most populated county.
Phoenix Children’s Hospital has announced three new facilities in the West Valley representing a nearly $200 million investment and Banner Health is also expanding its presence in the growing region.
20 years of TGen: Using genomics for medical benefit / Flinn Foundation
This year marks the 20th anniversary of both Arizona’s Bioscience Roadmap and TGen, which through its cutting-edge patient treatment, ground-breaking research, and commercialization, has played a key role in the success of the state’s bioscience initiative.